Posts by: Kara Elam

News

Two drug development powerhouses, Bristol Meyers Squibb and AbbVie, will collaborate to develop a treatment option for patients with relapsed extensive-stage small cell lung cancer (SCLC), a difficult to treat cancer because of ... Read more

June 29, 2016June 29, 2016

Novartis, Xencor Join Forces for Immuno-Oncology Therapies in New Licensing Agreement

News

Novartis has agreed to a collaborative and licensing venture with Xencor, a biopharma that specializes in the engineering of monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, ... Read more

June 9, 2016June 9, 2016

Preclinical Proof-of-Concept for Cancer Vaccine Announced

News

Nanobiotix has established preliminary preclinical proof-of-concept (POC) with its lead product NBTXR3 for a new program in immuno-oncology (IO). According to the company’s website, Nanobiotix, based in Paris, is “an oncology focused ... Read more

May 14, 2015May 14, 2015

First-In-Class Antibody Mixture Reduces Tumor Colorectal Cancer Progression

News

This week, researchers from the Vall d’Hebron University (VHU) Hospital’s Vall d’Hebron Institute of Oncology (VHIO) in Barcelona, Spain, have released results from a study showing that a therapeutic agent ... Read more

March 16, 2015March 16, 2015

Researchers Discover Tetanus Shot Can Successfully Aid in Brain Cancer Treatment

News

Researchers at Duke’s Cancer Institute (DCI) and the Preston Robert Tisch Brain Tumor Center have made a remarkable discovery that may have direct implications on how solid cancerous tumors are ... Read more